Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727-7 Published 2020 MarKleffel S, Posch C, Barthel SR, et al. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote
PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727-742. Published 2020 Mar 1. Kleffel S, Posch C, Barthel SR, et al. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth. Cell. 2015;162(6):1242-1256. doi:10.1016/j.cell.2015.08.052...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020,10(3): 727-742. [2] Tang Q, Chen Y, Li X, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in ...
(8) Han, Y., Liu, D., & Li, L. (2020). PD-1/PD-L1 pathway: current researches in cancer. American journal of cancer research, 10(3), 727–742. (9) Frigault MJ, Armand P, Redd RA, Jeter E, Merryman RW, Coleman KC, Herrera AF, Dahi P, Nieto Y, LaCasce AS, Fisher DC...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020,10(3): 727-742. [2] Tang Q, Chen Y, Li X, et al. The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Imunol. 2022, 13: 964442...
Cancer immunotherapy has recently shown promising antitumor effects in various types of tumors. Among all immune checkpoints, the PD-1/PD-L1 pathway plays an important role in the immune evasion of tumor cells, making it a potent target in antitumor immunity. Accordingly, antibodies targeting the...
8.Han Y, Liu D, LiL. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. 9.Managingtoxicities associated with immune checkpoint inhibitors: ...
Research Progress of PD-1/PD-L1 Inhibitors in Metastatic Colorectal Cancer XU Silei1,2, MO Wenhui1,2, HE Xia1,2, BAI Niuniu1,3, YUAN Mengying1,2, LI Zhimin1,2, BAI Yifeng4, ZHANG Jiao1,2,5, LIU Hao1,2 Author information+ ...
8.Han Y, Liu D, LiL. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. 9.Managingtoxicities associated with immune checkpoint inhibitors: consensusrecommendations from the Society for Immunotherapy of Cancer (...
[1] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer[J]. American Journal of Cancer Research, 2020, 10(3):727-742. [2] Attili I, Tarantino P, Passaro A, et al. Strategies to overc...